When you enroll in a GLP-1 telehealth program, you're trusting that the medication shipped to your door was compounded by a legitimate, licensed pharmacy using quality ingredients under appropriate conditions. But can you actually verify that?
We attempted to independently verify the compounding pharmacy behind 15 major GLP-1 telehealth programs. The process revealed a wide spectrum of transparency — from providers who proudly name their pharmacy partners to those who treat pharmacy sourcing as a trade secret.
Our Methodology
For each provider, we attempted the following steps:
- Check the website for named pharmacy partners or pharmacy credentials
- Review the FAQ and terms of service for pharmacy disclosures
- Contact customer support to ask which pharmacy compounds their medications
- If a pharmacy was named, verify its license through the relevant state pharmacy board
- Check for 503A or 503B registration and any FDA inspection history
- Look for PCAB (Pharmacy Compounding Accreditation Board) or similar third-party accreditation
What We Found
Category 1: Fully transparent (5 of 15)
Five providers named their compounding pharmacy on their website or disclosed it readily when asked. We were able to verify each pharmacy's state license, confirm its registration type (503A or 503B), and in some cases review FDA inspection reports. These providers view pharmacy transparency as a competitive advantage — and they're right.
Category 2: Disclosed on request (4 of 15)
Four providers didn't name their pharmacy on their website but provided the information when we contacted customer support. Response times ranged from 24 hours to 5 business days. The pharmacies we verified were all legitimately licensed, suggesting these providers aren't hiding anything problematic — they just don't lead with pharmacy credentials in their marketing.
Category 3: Vague or evasive (4 of 15)
Four providers gave vague answers when asked about their pharmacy. Responses included "we work with licensed US pharmacies" (without naming them), "our pharmacy partnerships are proprietary," and "we can't disclose that information for competitive reasons." When pressed, support representatives either escalated the question to teams that never responded or repeated the same non-answer.
Category 4: Unverifiable (2 of 15)
Two providers gave us pharmacy names that we couldn't verify through state pharmacy board databases. In one case, the pharmacy name didn't appear in any state registry. In the other, the license was listed as expired. We gave both providers the opportunity to clarify, and neither responded.
What to Look For
When evaluating a GLP-1 provider's pharmacy credentials, these are the checkpoints that matter:
- Named pharmacy: Can the provider tell you exactly which pharmacy compounds your medication?
- Verifiable license: Can you look up the pharmacy in its state's board of pharmacy database and confirm an active, current license?
- 503A or 503B classification: Is the pharmacy a 503A (state-regulated, patient-specific prescriptions) or 503B (FDA-registered, bulk compounding)? Each has different oversight structures.
- Accreditation: Does the pharmacy hold PCAB accreditation or equivalent third-party quality certification?
- FDA inspection history: For 503B facilities, has the FDA inspected them? What were the findings? (This information is publicly available through the FDA's inspection database.)
These providers are transparent about their pharmacy partnerships:
Providers Worth Investigating
We evaluated these programs based on the criteria discussed in this article. Listings are paid partnerships — our analysis is independent.